American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 569.e1-569.e6 , December 2009

Cytologic regression in women with atypical squamous cells of unknown significance and negative human papillomavirus test

Received 8 December 2008 ,Revised 29 March 2009 ,Accepted 26 May 2009.

References 

  1. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytologic abnormalities. JAMA. 2002;287:2120–2129
  2. Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103:304–309
  3. Solomon D, Schiffman M, Tarone R ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293–299
  4. Kendall BS, Bush AC, Olsen CH, Zahn CM. Reflex high risk human papillomavirus testing for women with atypical squamous cells of undetermined significance in cytologic smears: effects since implementation in a large clinical practice. Am J Clin Pathol. 2005;123:524–528
  5. Selvaggi SM. ASC-US and high-risk HPV testing: performance in daily clinical practice. Diagn Cytopathol. 2006;34:731–733
  6. Zielinski DG, Snijders PJ, Rozendaal L, et al. High-risk HPV testing in women with borderline and mild dyskaryosis: long term follow-up data and clinical relevance. J Pathol. 2001;195:300–306
  7. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet. 2001;358:782–783
  8. Solomon D, Davey D, Kurman R, et al. Forum Group Members; Bethesda 2001 Workshop The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–2119
  9. Östor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynaecol Pathol. 1993;12:186–192
  10. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91:252–258
  11. Syrjänen S, Shabalova IP, Petrovichev N, et al. Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study). Eur J Obstet Gynecol Reprod Biol. 2005;119:219–227
  12. Menezes GA, Wakely PE, Stripe DM, Nuovo GJ. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy. Cancer. 2001;93:357–363
  13. Saminathan T, Lahoti C, Kannan V, Kline TS. Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol. 1994;11:226–230
  14. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including “pseudokoilocytosis.”. Mod Pathol. 1995;8:408–412
  15. Negri G, Rigo B, Vittadello F, Egarter-Vigl E, Mian C. Human papillomavirus typing with Hybrid Capture II on archived liquid-based cytologic specimens: is HPV typing always reproducible?. Am J Clin Pathol. 2004;122:90–93

 Cite this article as: Wang S, Lang JH, Cheng XM. Cytologic regression in women with atypical squamous cells of unknown significance and negative human papillomavirus test. Am J Obstet Gynecol 2009;201:569.e1-6.

PII: S0002-9378(09)00559-6

doi: 10.1016/j.ajog.2009.05.048

American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 569.e1-569.e6 , December 2009

Article Tools

* Image Usage & Resolution